期刊论文

Therapeutic effect of modified Salvia miltiorrhiza decoction in treatment of primary hyperlipidemia with arteriosclerosis：a summary of 40 cases

中文

湖南中医杂志

1003-7705

2013

29

7

12-14

10.16808/j.cnki.issn1003-7705.2013.07.005

国家自然科学基金资助项目（编号:30973750）；

本校为第一机构

目的:观察加味丹参饮对原发性高脂血症合并动脉硬化患者血脂、超敏C反应蛋白(hs-CRP)的影响及治疗高脂血症的临床疗效.方法:将80例患者随机分为加味丹参饮治疗组和血脂康对照组,连续治疗8周.观察治疗前后两组患者血清总胆固醇(TC)、三酰甘油TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、载脂蛋白A(APOAI)、载脂蛋白B(APOB)和hs-CRP变化及治疗高脂血症的临床疗效.结果:经治疗后两组患者TC、TG、LDL-C、APOB和hs-CRP水平均显著低于治疗前(P＜0.05或P＜0.01),HDL-C 、APOAI较治疗前亦明显升高(P＜0.05),两组比较差异无统计学意义(P＞0.05).结论:加味丹参饮通过降低血脂、抗炎等机制对预防冠心病...

Objective：To observe the effects of modified Salvia miltiorrhiza decoction on the blood lipid and high sensitivity C-reactive protein（hs-CRP） in patients with primary hyperlipidemia plus arteriosclerosis and its clinical efficacy in the treatment of hyperlipidemia.Methods：Eighty patients with primary hyperlipidemia plus arteriosclerosis were randomly divided into modified Salvia miltiorrhiza decoction group and Xuezhikang capsule group.The course of treatment was 8 weeks for both groups.The therapeutic effects were assessed based on serum l...